when will glp 1 drugs become generic GLP-1 Medications be Available? Generic GLP-1 medications: Current and

[DOI] [PubMed] [Google Scholar] 183.Bhutani S., Kahn E., Tasali E., Schoeller D.A

A safe prescribing decision also considers: eligibility and NHS pathway availability comorbidities and concurrent medicines tolerability and dose escalation patient preference and expectations capacity for follow-up and monitoring The difference between semaglutide and tirzepatide should therefore be framed as a clinical comparison, not a direct consumer recommendation

Serious side effects, such as pancreatitis or thyroid issues, are rare

Schedule a Call with Our Analyst Team @ Regional Insights: North America led the GLP-1 receptor agonists market in 2025 and accounted for about 45% of the total market share, mainly attributed to its strong presence in the U.S